These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Ueberham E; Löw R; Ueberham U; Schönig K; Bujard H; Gebhardt R Hepatology; 2003 May; 37(5):1067-78. PubMed ID: 12717387 [TBL] [Abstract][Full Text] [Related]
4. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury. Hagiwara S; Otsuka T; Yamazaki Y; Kosone T; Sohara N; Ichikawa T; Sato K; Kakizaki S; Takagi H; Mori M Liver Int; 2008 Jan; 28(1):126-31. PubMed ID: 17976157 [TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482 [TBL] [Abstract][Full Text] [Related]
8. TGF beta1 and PDGF AA override collagen type I inhibition of proliferation in human liver connective tissue cells. Geremias AT; Carvalho MA; Borojevic R; Monteiro AN BMC Gastroenterol; 2004 Dec; 4():30. PubMed ID: 15579200 [TBL] [Abstract][Full Text] [Related]
9. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model. Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liu X; Hu H; Yin JQ Liver Int; 2006 Feb; 26(1):8-22. PubMed ID: 16420505 [TBL] [Abstract][Full Text] [Related]
11. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Pinzani M; Milani S; Herbst H; DeFranco R; Grappone C; Gentilini A; Caligiuri A; Pellegrini G; Ngo DV; Romanelli RG; Gentilini P Am J Pathol; 1996 Mar; 148(3):785-800. PubMed ID: 8774134 [TBL] [Abstract][Full Text] [Related]
12. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model. Chen MH; Chen JC; Tsai CC; Wang WC; Chang DC; Tu DG; Hsieh HY J Ethnopharmacol; 2005 Feb; 97(1):7-13. PubMed ID: 15652268 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies. Spee B; Arends B; van den Ingh TS; Brinkhof B; Nederbragt H; Ijzer J; Roskams T; Penning LC; Rothuizen J Liver Int; 2006 Aug; 26(6):716-25. PubMed ID: 16842329 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice. Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702 [TBL] [Abstract][Full Text] [Related]
16. Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-beta1. Doh KO; Jung HK; Moon IJ; Kang HG; Park JH; Park JG Int J Mol Med; 2008 Jan; 21(1):33-9. PubMed ID: 18097613 [TBL] [Abstract][Full Text] [Related]
17. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365 [TBL] [Abstract][Full Text] [Related]
18. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis]. Li Q; Zhou X; Yu J; Qian W; Xu KS Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103 [TBL] [Abstract][Full Text] [Related]
19. [The role of TGFbeta1 and IL-13 in cellular signal transduction of hepatic fibrosis of schistosomiasis]. Li J; Wang W; Shen JL Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Aug; 27(4):357-60. PubMed ID: 20066997 [TBL] [Abstract][Full Text] [Related]
20. PDGF-A, -C, and -D but not PDGF-B increase TGF-beta1 and chronic rejection in rat cardiac allografts. Tuuminen R; Nykänen AI; Krebs R; Soronen J; Pajusola K; Keränen MA; Koskinen PK; Alitalo K; Lemström KB Arterioscler Thromb Vasc Biol; 2009 May; 29(5):691-8. PubMed ID: 19213942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]